Recent Comments
Exjade receives black box warning

Exjade receives black b...

Novartis Oncology and FDA notified healthcare professionals about recent changes in the Prescribing Information (PI) for Exjade, indicated for the treatment of chronic iron overload due to blood transfusions in patients 2 years of age and older. New language was added to the...
Baxter HomeChoice Dialysis Systems Recalled

Baxter HomeChoice Dialy...

Company, Product(s): Baxter Healthcare Corporation HomeChoice and HomeChoice PRO Automated Peritoneal Dialysis Systems Recall Class: Class I Date Recall Initiated: January 8, 2010 Product Names: Baxter Healthcare Corporation, HomeChoice and HomeChoice PRO Automated Peritoneal Dialysis...
And the Avandia debate rages on – Senate Committee blasts FDA and GSK

And the Avandia debate ...

Big Pharma is on the run as dirty secrets are aired. The Senate Finance Committee issued a report alleging that GSK, the makers of Avandia, intimidated physicians and knew about the cardiovascular risks of Avandia long before announcing them to the public. The following is the joint press...
Indecisive over Avandia, FDA risks lives

Indecisive over Avandia...

The FDA is at it again. The bungling agency’s primary responsibility is to ensure that prescription drugs, like Avandia, are EFFECTIVE and SAFE. Are we asking too much for an agency that is essentially the DMV with doctors? I think so. The FDA was built on the noble premise that...